Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2021-08-24 Purchase | 2021-08-25 9:21 pm | Population Health Investment Co. Inc. | PHIC | MEANWELL CLIVE Chief Executive Officer | 16,400 | $9.7969 | $160,669 | 31,300 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2024-02-06 Conversion | 2024-02-08 4:40 pm | N/A N/A | Fractyl Health Inc. | GUTS | MEANWELL CLIVE Director | 874,242 | $0 | 277,890 (Indirect) | View |
| 2024-02-01 Option Award | 2024-02-05 5:10 pm | N/A 2034-01-31 | Fractyl Health Inc. | GUTS | MEANWELL CLIVE Director | 45,000 | $0 | 45,000 (Direct) | View |
Ownership | 2024-02-01 6:18 pm | N/A N/A | Fractyl Health Inc. | GUTS | MEANWELL CLIVE Director | 0 | $0 | 277,890 (Indirect) | View |
| 2023-11-09 Disposition | 2023-11-09 4:06 pm | N/A 2030-10-13 | EQRx Inc. | EQRX | MEANWELL CLIVE Director | 457,682 | $0 | 0 (Direct) | View |
| 2023-05-23 Option Award | 2023-05-25 6:42 pm | N/A 2033-05-22 | Invivyd Inc. | IVVD | MEANWELL CLIVE Director | 50,000 | $0 | 50,000 (Direct) | View |
| 2023-01-01 Option Award | 2023-01-04 9:53 pm | N/A 2024-12-17 | EQRx Inc. | EQRX | MEANWELL CLIVE Director | 226 | $0 | 43,172 (Direct) | View |
| 2022-09-30 Option Award | 2022-10-04 8:07 pm | N/A 2032-09-30 | EQRx Inc. | EQRX | MEANWELL CLIVE Director | 101,010 | $0 | 101,010 (Direct) | View |
| 2022-06-22 Option Award | 2022-06-24 5:01 pm | N/A 2032-06-21 | Adagio Therapeutics Inc. | ADGI | MEANWELL CLIVE Director 10% Owner | 150,000 | $0 | 150,000 (Direct) | View |
Ownership | 2022-03-30 9:57 pm | N/A N/A | Adagio Therapeutics Inc. | ADGI | MEANWELL CLIVE See Explanation of Responses. | 0 | $0 | 1,201,680 (Indirect) | View |
| 2021-12-17 Option Award | 2021-12-20 9:56 pm | N/A 2030-10-13 | EQRx Inc. | EQRX | MEANWELL CLIVE Director | 356,446 | $0 | 356,446 (Direct) | View |
| 2020-01-06 Disposition | 2020-01-06 1:28 pm | N/A N/A | MEDICINES CO | MDCO | MEANWELL CLIVE Chief Innovation Officer | 1,994,034 | $0 | 0 (Direct) | View |
| 2019-12-27 Exercise | 2019-12-31 7:54 pm | N/A N/A | MEDICINES CO | MDCO | MEANWELL CLIVE Chief Innovation Officer | 60,000 | $7.31 | 600,340 (Direct) | View |
| 2019-12-27 Tax Withholding | 2019-12-31 7:54 pm | N/A N/A | MEDICINES CO | MDCO | MEANWELL CLIVE Chief Innovation Officer | 352,141 | $84.78 | 600,340 (Direct) | View |
| 2019-12-27 Exercise | 2019-12-31 7:54 pm | N/A N/A | MEDICINES CO | MDCO | MEANWELL CLIVE Chief Innovation Officer | 11,483 | $30.55 | 600,340 (Direct) | View |
| 2019-12-27 Exercise | 2019-12-31 7:54 pm | N/A N/A | MEDICINES CO | MDCO | MEANWELL CLIVE Chief Innovation Officer | 240,000 | $17.45 | 600,340 (Direct) | View |
| 2019-12-27 Exercise | 2019-12-31 7:54 pm | N/A N/A | MEDICINES CO | MDCO | MEANWELL CLIVE Chief Innovation Officer | 150,000 | $22.04 | 600,340 (Direct) | View |
| 2019-12-27 Exercise | 2019-12-31 7:54 pm | N/A N/A | MEDICINES CO | MDCO | MEANWELL CLIVE Chief Innovation Officer | 15,620 | $13.54 | 600,340 (Direct) | View |
| 2019-12-27 Exercise | 2019-12-31 7:54 pm | 2014-03-19 2020-02-19 | MEDICINES CO | MDCO | MEANWELL CLIVE Chief Innovation Officer | 541,671 | $0 | 600,340 (Direct) | View |
| 2019-12-27 Exercise | 2019-12-31 7:54 pm | N/A N/A | MEDICINES CO | MDCO | MEANWELL CLIVE Chief Innovation Officer | 64,568 | $31.49 | 600,340 (Direct) | View |